Abstract
Summary
Synthetic 5-hydroxy-tryptamine creatinine sulfate failed to enhance clot retraction and prothrombin utilization during clotting of platelet-free human plasma. These results are at variance with recently reported findings.
Get full access to this article
View all access options for this article.